Bill > SF3087

This bill modifies restrictions on the sale of over-the-counter allergy medications containing ephedrine or pseudoephedrine (known as methamphetamine precursor drugs) in Minnesota. The bill adjusts several key provisions for retailers selling these medications, including limiting over-the-counter sales to packages containing 3.6 grams of the drug, requiring sales to be made only by licensed pharmacy personnel, and mandating that buyers provide photo identification and sign a document detailing their purchase. The bill maintains strict purchase limitations, preventing individuals from buying more than 7.2 grams of these drugs within a 30-day period and prohibiting sales to people under 18 years old. Retailers must display these medications behind checkout counters and keep purchase records for at least three years. Violations can result in misdemeanor charges with potential fines up to $1,000 and/or 90 days imprisonment. The bill also provides some exemptions, such as for pediatric products, certain drug formulations, and wholesale distributors, and preempts local ordinances that might conflict with these state-level regulations, ultimately aiming to reduce the potential misuse of these medications in methamphetamine production.

Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF3087&ssn=0&y=2025